Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
16.72
-0.33 (-1.94%)
At close: Jun 26, 2026, 4:00 PM EDT
16.77
+0.05 (0.30%)
After-hours: Jun 26, 2026, 4:10 PM EDT
AAPG Market Cap
AAPG has a market cap or net worth of $1.43 billion as of June 26, 2026. Its market cap has decreased by -40.73% in one year.
Market Cap
1.43B
Enterprise Value
1.36B
1-Year Change
-40.73%
Ranking
Category
Stock Price
$16.72
Market Cap Chart
Since the IPO on January 24, 2025, AAPG's market cap has decreased from $1.48B to $1.43B, a decrease of -3.55%. That is a compound annual growth rate of -2.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.43B | -42.10% |
| Dec 31, 2025 | 2.47B | 66.57% |
| Jan 24, 2025 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.57B |
| Damora Therapeutics | 1.56B |
| Capricor Therapeutics | 1.53B |
| Hemab Therapeutics Holdings | 1.51B |
| MapLight Therapeutics | 1.51B |
| Savara | 1.50B |
| Novavax | 1.46B |
| Inhibrx Biosciences | 1.39B |